ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd (SHA:603976)
China flag China · Delayed Price · Currency is CNY
20.59
-0.10 (-0.48%)
Feb 13, 2026, 3:00 PM CST

SHA:603976 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
645.88797.8896.9793.01793.62500.4
Other Revenue
3.333.333.743.193.041.59
649.21801.12900.65796.2796.66501.98
Revenue Growth (YoY)
-22.94%-11.05%13.12%-0.06%58.70%-3.67%
Cost of Revenue
551.94653.93759.02642.95598.3395.23
Gross Profit
97.27147.2141.63153.25198.36106.75
Selling, General & Admin
51.3757.5357.1357.4658.9345.68
Research & Development
13.8120.2623.4319.1112.088.25
Other Operating Expenses
6.590.029.329.549.228.16
Operating Expenses
71.0277.5290.7686.7381.8262.23
Operating Income
26.2569.6750.8766.52116.5444.52
Interest Expense
-20.98-20.95-21.26-19.61-13.08-0.29
Interest & Investment Income
8.099.89.178.399.1210.76
Currency Exchange Gain (Loss)
0.070.07-0.25-0.040.730.07
Other Non Operating Income (Expenses)
2.85-0.04-0.04-0.060.05-0.21
EBT Excluding Unusual Items
16.2758.5638.4955.2113.3754.84
Gain (Loss) on Sale of Investments
0.430.471.05-0.944.76-
Gain (Loss) on Sale of Assets
-5.39-5.3-0.19-1.32-0.530
Asset Writedown
0.98-----0.7
Legal Settlements
-----1.87-
Other Unusual Items
6.536.495.475.6110.257.23
Pretax Income
18.8360.2144.8358.55125.9761.38
Income Tax Expense
1.186.964.56-6.2219.378.33
Net Income
17.6553.2540.2764.77106.653.05
Net Income to Common
17.6553.2540.2764.77106.653.05
Net Income Growth
-68.76%32.24%-37.83%-39.24%100.95%-13.11%
Shares Outstanding (Basic)
149152149151150152
Shares Outstanding (Diluted)
149152149151150152
Shares Change (YoY)
-2.07%2.01%-0.99%0.32%-0.94%-0.70%
EPS (Basic)
0.120.350.270.430.710.35
EPS (Diluted)
0.120.350.270.430.710.35
EPS Growth
-68.10%29.63%-37.21%-39.44%102.86%-12.50%
Free Cash Flow
93.8540.2104.22-237.66-32.58-54.1
Free Cash Flow Per Share
0.630.260.70-1.58-0.22-0.36
Dividend Per Share
0.2460.3460.2000.0600.3080.036
Dividend Growth
-18.00%73.00%233.33%-80.52%755.56%-88.89%
Gross Margin
14.98%18.37%15.72%19.25%24.90%21.27%
Operating Margin
4.04%8.70%5.65%8.35%14.63%8.87%
Profit Margin
2.72%6.65%4.47%8.13%13.38%10.57%
Free Cash Flow Margin
14.46%5.02%11.57%-29.85%-4.09%-10.78%
EBITDA
147.33184.05156.3152.62182.9898.01
EBITDA Margin
22.69%22.97%17.36%19.17%22.97%19.53%
D&A For EBITDA
121.08114.37105.4386.1166.4553.49
EBIT
26.2569.6750.8766.52116.5444.52
EBIT Margin
4.04%8.70%5.65%8.35%14.63%8.87%
Effective Tax Rate
6.26%11.56%10.17%-15.38%13.56%
Revenue as Reported
649.21801.12900.65796.2796.66501.98
Advertising Expenses
---0.62.021.14
Source: S&P Global Market Intelligence. Standard template. Financial Sources.